Haupt Pharma: Press Releases
Haupt Pharma Invests in Modern Tablet Compression Technology for the Efficient Production of Solid Dosage Forms with Adhesive Tendencies
Haupt Pharma, one of Europe's leading pharmaceutical companies for contract development and contract manufacturing, installed its new tablet press, Fette 1200i, at the Regensburg site in August...
Haupt Pharma Passes FDA Inspection at Haupt Pharma Amareg
Haupt Pharma, one of Europe's leading contract developers and manufacturers, has successfully passed an inspection by the US Food and Drug Administration (FDA) at its site in Regensburg,...
Haupt Pharma Fulfils International Food Standard
Haupt Pharma, one of the largest pharmaceutical contract manufacturers and developers in Europe, now also fulfils the high demands of the International Food Standard (IFS). During the...
Haupt Pharma Optimises Production in Wolfratshausen
Haupt Pharma, one of the largest pharmaceutical contract manufacturers and developers in Europe, has commissioned new equipment for filling and packing liquids at its Wolfratshausen site. Now,...
Haupt Pharma Introduces New Line for Packaging Cytostatics and Immunosuppressives
Haupt Pharma Amareg has put a new Uhlmann blister line into operation for packaging cytostatics and immunosuppressives. This line allows the packaging of tablets or capsules in PVC/PVDC...
Haupt Pharma Presents Portfolio at the ICSE
At the international trade fair for pharmaceutical outsourcing, the International Contract Services Expo (ICSE) in Paris from 5-7 October, the Haupt Pharma Group, one of the largest...
Haupt Pharma Increases Capacity with New Laboratories for Analytical Development
In April 2010, Haupt Pharma Amareg inaugurated several new purpose-built laboratories for pharmaceutical development, and in so doing increased its capacity for analytical development...
Haupt Pharma: New Separate Production Area for Sex Hormone-Containing Solids Sets Standards for EHS and GMP
Handling of sex hormones as highly potent, pharmacologically active substances requires increasingly complex facilities and machinery to protect the product, the workforce and the...
Haupt Pharma at ICSE/CPhI in Hall 8, Booth 8A26 – Full Service in Pharmaceutical Development and Contract Manufacturing
Due to increasing pressure regarding cost and complexity, many pharmaceutical companies prefer to collaborate only with a few contract manufacturers and bundle their activities with a strong...
Haupt Pharma: New Filling System for Sterile Products Guarantees the Highest Quality and Efficiency
The requirements for quality and efficiency in the manufacturing of sterile products are steadily becoming more stringent. Haupt Pharma meets these demands by continuously investing in...
Haupt Pharma: New Packaging Line Offers Even Greater Flexibility
High performance and efficiency are important aspects for a successful collaboration in contract manufacturing. To continue to be a competent contact partner for our customers in the...
Haupt Pharma Acquires Pfizer’s Plant in Italy
Haupt Pharma, one of the world's largest pharmaceutical contract manufacturers and developers, announced today that it has completed the purchase of a Pfizer production site in Latina,...
Norbert Schwella Appointed Chief Financial Officer (CFO) of Haupt Pharma
Mr Norbert Schwella has been appointed as the chief financial officer (CFO) and a member of the extended executive board of Haupt Pharma. The function of the CFO was created with regard to...
Merger Strengthens the Market Position of the Pharmaceutical Contract Manufacturer Haupt Pharma
On 1 September 2008, the previously announced consolidation of the pharmaceutical contract manufacturers and developers AMAREG, Wülfing Pharma and Haupt Pharma, comes into force. This will...
Haupt Pharma is Exhibiting at the CPhI Worldwide 2008
Please visit Haupt Pharma at the CPhI Worldwide 2008. You will find us in hall 4.2 at booth number 42 J 17. Venue: Messe Frankfurt, Germany Date: 30 September – 2 October ...
Merger of Haupt Pharma, Amareg and Wülfing Pharma
Invita AG, an investment company that focuses on the pharmaceutical sector, is to merge its portfolio companies Amareg, Haupt Pharma and Wülfing Pharma as of September 1, 2008. The merger of...
Japanese Accreditation Certificate for Haupt Pharma Livron
Haupt Pharma Livron have received an accreditation certificate from Japan's Ministry of Health, Labour and Welfare. With this the company has been given the go-ahead as foreign...
New Production Site on Malta
Haupt Pharma expands its production line for high potent drugs. By engaging in a cooperation with Siegfried Generics Malta the company is now also active on Malta and will extend its...
Werner Bürk Appointed Chief Sales and Development Officer
With effect from April 1, 2007 the supervisory board has appointed Mr Werner Buerk to the management board of Haupt Pharma AG. The main focus of his new responsibility will be sales, marketing,...
Haupt Pharma Business Development GmbH is Renamed and Shifts its Headquarters
Haupt Pharma Business Development GmbH has shifted its company headquarters from Berlin to the Haupt Pharma site in Wolfratshausen. At the same time with the new financial year 2007 the company...
Centralization of the Sales Department at Haupt Pharma
Along with the start of his function in the management board, the new sales organisation Mr Buerk has set up will come into operation. The sales staff are now centrally managed and employed...
Haupt Pharma Aims at the Stock Market
The pharmaceutical contract manufacturer Haupt Pharma AG is preparing for IPO. The IPO should take place at the beginning of 2008 or 2009. Until then the company, which is mainly in private...
Boehringer Ingelheim Seiyaku to De-merge and Divest its Ampoule Production Site
Boehringer Ingelheim Seiyaku (Headquarters: Higashine-shi, Yamagata, president: Dr Gerhard Gigl) and Haupt Pharma announced today, that Boehringer Ingelheim Seiyaku, Nippon Boehringer...
Twitter